CLGN CollPlant Biotechnologies Ltd. Year-over-year earnings per share growth for the last twelve months
Patents for plant-based collagen for 3D printing provide CollPlant Biotechnologies (CLGN) with pricing power, although contracts with pharma behemoths temporarily limit pricing. This chart illustrates quarterly EPS dynamics based on GURU.Markets data, where the value 33.30 determines the parameter status. CollPlant Biotechnologies (CLGN) relies on recombinant protein production, delegating clinical trials to external CRO partners. The use of GMO plants guarantees raw material exclusivity and stable margins.
Analytical breakdowns for CollPlant Biotechnologies (CLGN)
- share price and expert price forecast:
- market capitalization data:
- book capitalization data:
- company liabilities and liquidity data:
Debt to Equity CollPlant Biotechnologies|CLGN - Long-Term Liabilities to Equity|Short-Term Debt to Equity collplant.com|CLGN - Company Debts|Debts to Book Capitalization CollPlant Ltd|CLGN - Company Long-Term Debts|Company Short-Term Debt CollPlant Biotechnologies|Quick Liquidity Indicator collplant.com
- earnings and market multiples details:
CLGN - Profit After Payment of Taxes|Future Profit CollPlant Biotechnologies|CLGN - Company Value to Net Income|Forward P/E Multiple collplant.com|CLGN - Price/Earnings to Growth Ratio|EV/EBITDA Multiple CollPlant Ltd|CLGN - Operating income before deduction of amortization|Earnings per share for the last twelve months CollPlant Biotechnologies|CLGN - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months collplant.com|CLGN - Net earnings per one share growth for the current year|Earnings growth forecast for next year CollPlant Biotechnologies
Fundamental valuation:CollPlant - CLGN
Stable royalties from the licensing of plant-based collagen in aesthetic medicine directly determine the growth rate of earnings per share for CollPlant Biotechnologies (CLGN). This indicator measures the percentage change in net income per quarter, reflecting the balance between institutional demand and market supply, which allows the quarterly EPS growth trend to identify the moment growth drivers are exhausted or the trend reversal point.
Competitor analysis
HCA: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Tenet Healthcare Corp|Year-over-year earnings per share growth for the last twelve months Fresenius Medical Care Corp|Earnings per share growth in annualized terms for the last twelve months Solventum Health SOLV|Year-over-year earnings per share growth for the last twelve months Encompass Health (EHC)|Year-over-year earnings per share growth for the last twelve months UHS (uhsinc.com)|Year-over-year earnings per share growth for the last twelve months DaVita DVA|RadNet Inc - Year-over-year earnings per share growth for the last twelve months|OPCH - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months SGRY|Premier, Inc. (PINC) - Year-over-year earnings per share growth for the last twelve months|EYE (nationalvision.com) - Year-over-year earnings per share growth for the last twelve months|PGNY (Progyny) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Ardent Health|Year-over-year earnings per share growth for the last twelve months Select Medical Corp (SEM)|Astrana Corp - Year-over-year earnings per share growth for the last 12 months|Pediatrix Medical - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months USPH (US Physical Therapy)|PNTG: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months ORGO (Organogenesis Holdings Inc.)|NUTX: Quarterly EPS earnings growth|AUNA (Auna Corp) - Year-over-year earnings per share growth for the last twelve months|SBC (SBC Medical Group Inc) - Quarterly EPS earnings growth|evolus.com (EOLS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Community Health Systems, Inc. (CYH)|SKIN - Earnings per share growth in annualized terms for the last twelve months|MediWound - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months BTMD (Biote Corporation)|The Joint Corp. - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months docgo.com|PIII: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months gaintherapeutics.com|EUDA (EUDA Health Holdings Limited) - Quarterly EPS earnings growth|BMGL: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Cuprina Holdings (Cayman) Ltd (CUPR)|concordmedical.com - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months American Shared Hospital Services AMS|MEDIROM Healthcare Group Inc. (MRM) - Earnings per share growth in annualized terms for the last twelve months|ALBT - Year-over-year earnings per share growth for the last twelve months|DHAI: Year-over-year earnings per share growth for the last twelve months|Longevity Health Holdings (XAGE) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months newgenivf.com (NIVF)|ATIP (ATI Physical Therapy Inc.) - Quarterly EPS earnings growth|CMAX - Net earnings per share growth for the trailing year|Quarterly EPS earnings growth KDLY|Year-over-year net earnings per share change for the last twelve months ModivCare Corp|Quarterly EPS earnings growth NVOS (Novo Integrated Sciences)|SunLink Health Systems Inc. (SSY) - Earnings per share growth in annualized terms for the last twelve months|BACK - Year-over-year earnings per share growth for the last twelve months
